News
This photo taken in January 2024 shows an intelligent workshop of rice-derived recombinant human serum albumin of Healthgen ...
The drug candidates comprise modified versions of recombinant human interleukin ... connected to the company’s Fully Human Albumin Binding (FHAB) platform. Another drug, SON-1400 is a ...
Sonnet BioTherapeutics (SONN) announced positive findings from the first safety review of the expansion cohort in its Phase 1 SB101 clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results